全文获取类型
收费全文 | 3381篇 |
免费 | 206篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 124篇 |
妇产科学 | 46篇 |
基础医学 | 511篇 |
口腔科学 | 93篇 |
临床医学 | 262篇 |
内科学 | 786篇 |
皮肤病学 | 175篇 |
神经病学 | 215篇 |
特种医学 | 80篇 |
外科学 | 245篇 |
综合类 | 33篇 |
预防医学 | 193篇 |
眼科学 | 87篇 |
药学 | 286篇 |
中国医学 | 17篇 |
肿瘤学 | 406篇 |
出版年
2024年 | 4篇 |
2023年 | 42篇 |
2022年 | 67篇 |
2021年 | 111篇 |
2020年 | 56篇 |
2019年 | 83篇 |
2018年 | 118篇 |
2017年 | 89篇 |
2016年 | 87篇 |
2015年 | 90篇 |
2014年 | 135篇 |
2013年 | 139篇 |
2012年 | 266篇 |
2011年 | 247篇 |
2010年 | 188篇 |
2009年 | 129篇 |
2008年 | 197篇 |
2007年 | 228篇 |
2006年 | 254篇 |
2005年 | 205篇 |
2004年 | 193篇 |
2003年 | 185篇 |
2002年 | 177篇 |
2001年 | 26篇 |
2000年 | 26篇 |
1999年 | 25篇 |
1998年 | 30篇 |
1997年 | 29篇 |
1996年 | 22篇 |
1995年 | 26篇 |
1994年 | 15篇 |
1993年 | 13篇 |
1992年 | 11篇 |
1991年 | 7篇 |
1990年 | 12篇 |
1989年 | 15篇 |
1988年 | 5篇 |
1987年 | 10篇 |
1986年 | 7篇 |
1985年 | 8篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1982年 | 9篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1976年 | 1篇 |
1974年 | 2篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有3608条查询结果,搜索用时 69 毫秒
141.
Sota Todoriki Yui Hosoda Tae Yamamoto Mayu Watanabe Akiyo Sekimoto Hiroshi Sato Takefumi Mori Mariko Miyazaki Nobuyuki Takahashi Emiko Sato 《Toxins》2022,14(4)
Uremic sarcopenia is a serious clinical problem associated with physical disability and increased morbidity and mortality. Methylglyoxal (MG) is a highly reactive, dicarbonyl uremic toxin that accumulates in the circulatory system in patients with chronic kidney disease (CKD) and is related to the pathology of uremic sarcopenia. The pathophysiology of uremic sarcopenia is multifactorial; however, the details remain unknown. We investigated the mechanisms of MG-induced muscle atrophy using mouse myoblast C2C12 cells, focusing on intracellular metabolism and mitochondrial injury. We found that one of the causative pathological mechanisms of uremic sarcopenia is metabolic flow change to fatty acid synthesis with MG-induced ATP shortage in myoblasts. Evaluation of cell viability revealed that MG showed toxic effects only in myoblast cells, but not in myotube cells. Expression of mRNA or protein analysis revealed that MG induces muscle atrophy, inflammation, fibrosis, and oxidative stress in myoblast cells. Target metabolomics revealed that MG induces metabolic alterations, such as a reduction in tricarboxylic acid cycle metabolites. In addition, MG induces mitochondrial morphological abnormalities in myoblasts. These changes resulted in the reduction of ATP derived from the mitochondria of myoblast cells. Our results indicate that MG is a pathogenic factor in sarcopenia in CKD. 相似文献
142.
Amenamevir,a novel helicase–primase inhibitor,for treatment of herpes zoster: A randomized,double‐blind,valaciclovir‐controlled phase 3 study
下载免费PDF全文
![点击此处可从《The Journal of dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Makoto Kawashima Osamu Nemoto Mariko Honda Daisuke Watanabe Juichiro Nakayama Shinichi Imafuku Toshiyuki Kato Tsuneo Katsuramaki the study investigators 《The Journal of dermatology》2017,44(11):1219-1227
Amenamevir is a potent helicase–primase inhibitor and a novel class of antiviral agent other than nucleoside compounds, such as aciclovir, valaciclovir and famciclovir. This study is the first randomized, double‐blind, valaciclovir‐controlled phase 3 study to evaluate the efficacy and safety of amenamevir in Japanese patients with herpes zoster when treated within 72 h after onset of rash. A total of 751 patients were randomly assigned to receive either amenamevir 400 mg or 200 mg p.o. once daily or valaciclovir 1000 mg three times daily (daily dose, 3000 mg) for 7 days. The primary efficacy end‐point was the proportion of cessation of new lesion formation by day 4 (“day 4 cessation proportion”). The day 4 cessation proportions for amenamevir 400 and 200 mg and valaciclovir were 81.1% (197/243), 69.6% (172/247) and 75.1% (184/245), respectively. Non‐inferiority of amenamevir 400 mg to valaciclovir was confirmed by a closed testing procedure. Days to cessation of new lesion formation, complete crusting, healing, pain resolution and virus disappearance were evaluated as secondary end‐points. No significant differences were observed in any of the treatment groups. Amenamevir 400 and 200 mg were well tolerated as well as valaciclovir. The proportions of patients who experienced drug‐related adverse events were 10.0% (25/249), 10.7% (27/252) and 12.0% (30/249) with amenamevir 400 and 200 mg and valaciclovir, respectively. In conclusion, amenamevir 400 mg appears to be effective and well tolerated for treatment of herpes zoster in immunocompetent Japanese patients. 相似文献
143.
144.
Hidekazu Kato Fuyu Miyake Hiroko Shimbo Makoto Ohya Hidenori Sugawara Noriko Aida Rie Anzai Mariko Takagi Mitsuko Okuda Kyoko Takano Takahito Wada Mizue Iai Sumimasa Yamashita Hitoshi Osaka 《Brain & development》2014
Creatine transporter deficiency (CTD) is an example of X-linked intellectual disability syndromes, caused by mutations in SLC6A8 on Xq28. Although this is the second most frequent genetic cause of intellectual disabilities in Europe or America after Fragile X syndrome, information on the morbidity of this disease is limited in Japan. Using the HPLC screening method we have established recently, we examined samples of urine of 105 patients (73 males and 32 females) with developmental disabilities at our medical center. And we have found a family with three ID boys with a novel missense mutation in SLC6A8. This is the second report of a Japanese family case of CTD. A systematic diagnostic system of this syndrome should be established in Japan to enable us to estimate its frequency and treatment. 相似文献
145.
Probucol and atorvastatin decrease urinary 8-hydroxy-2'-deoxyguanosine in patients with diabetes and hypercholesterolemia 总被引:1,自引:0,他引:1
Endo K Miyashita Y Sasaki H Ebisuno M Ohira M Saiki A Koide N Oyama T Takeyoshi M Shirai K 《Journal of atherosclerosis and thrombosis》2006,13(1):68-75
To clarify whether probucol and statins suppress oxidative stress in diabetic patients, we studied the effects of probucol and the statin atorvastatin on urinary 8-hydroxy-2'deoxyguanosine (8-OHdG) levels in diabetics with hypercholesterolemia. A randomized, open study was performed on a total of 36 patients with type 2 diabetes and hypercholesterolemia. The patients were randomly assigned to a probucol group (500 mg/day, n = 18) or an atorvastatin group (10 mg/day, n = 18). During three months, total- and LDL-cholesterol decreased significantly in both groups. LDL-cholesterol was significantly lower in the atorvastatin group than probucol group. HDL-C decreased significantly in the probucol group and did not change in the atorvastatin group. 8-OHdG decreased significantly in both groups after 3 months; 12.4 +/- 7.5 to 8.1 +/- 4.2 ng/mg/Cr in the atorvastatin group (p < 0.05) and 12.3 +/- 8.8 to 6.8 +/- 2.6 ng/mg/Cr in the probucol group (p < 0.05), and these changes did not differ significantly between the two groups. But, in patients with high 8-OHdG levels (more than 10 ng/mg/Cr) before administration, urinary 8-OHdG decreased significantly from 19.5 +/- 4.9 to 9.2 +/- 3.4 ng/mg Cr (p < 0.01) in the atorvastatin group, and from 19.7 +/- 8.2 to 6.67 +/- 2.2 ng/mg Cr (p < 0.01) in the probucol group. Urinary 8-OHdG was significantly lower in the probucol group than in the atorvastatin group after the second and third months of administration (p < 0.05). These results suggest that while probucol and atorvastatin both reduce systemic oxidative stress, probucol might be the more useful in patients with strong oxidative stress. 相似文献
146.
147.
Mariko O. Uchida Takeshi Arimitsu Kiyomi Yatabe Kazushige Ikeda Takao Takahashi Yasuyo Minagawa 《Developmental psychobiology》2018,60(2):140-149
While the influence of the mother's voice on neonatal heart‐rate response and its relevant activity on cerebral cortex and the autonomic nervous system (ANS) are well known, few studies have assessed its influence on respiratory activity. We investigated the relationship among the respiration rate, the delta wave amplitudes through electroencephalography, and the basal state of ANS through the respiratory variability index while 22 full‐term neonates hear their mother's voice and an unknown voice. It was found that when respiratory variability was large, a transient (<5 s) change in respiration rates was observed in response to an unknown voice, while a greater increase in the delta wave amplitude was observed in the frontal lobe than the parietal one in response to the mother's voice. Conversely, when respiratory variability was small, a sustained increase (>10 s) in respiration rates was observed in response to the mother's voice, while a greater increase in the delta wave amplitude was found in both the frontal and parietal lobes. These results suggest that the basal state of ANS influences the latency of increases in respiration rates. Furthermore, induced by the mother's voice, transient increases in respiration rates are reduced in association with frontal lobe activity, and sustained increases in respiration rates are promoted in association with frontal and parietal lobe activities. 相似文献
148.
149.
Mariko Harada-Shiba Itaru Takamisawa Kanjiro Miyata Takehiko Ishii Nobuhiro Nishiyama Keiji Itaka Kenji Kangawa Fumiki Yoshihara Yujiro Asada Kinta Hatakeyama Noriya Nagaya Kazunori Kataoka 《Molecular therapy》2009,17(7):1180-1186
Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by progressive PAH and right ventricular failure. Despite recent advances in therapeutic approaches using prostanoids, endothelin antagonists, and so on, PAH remains a challenging condition. To develop a novel therapeutic approach, we have established a nonviral gene delivery system of poly(ethylene glycol) (PEG)-based block catiomers, which form a polyplex nanomicelle with a nanoscaled core–shell structure in the presence of DNA. The polyplex nanomicelle from PEG-b-poly{N-[N-(2-aminoethyl)-2-aminoethyl]aspartamide} (PEG-b-P[Asp(DET)]), having ethylenediamine units at the side chain, showed ~100-fold increase in luciferase transgene expression activity in mouse lung via intratracheal administration with a minimal toxicity compared with the polyplex from linear poly(ethylenimine) (LPEI). The transfection activity was highest on day 3 after administration and remained detectable until day 14. PEG-b-P[Asp(DET)] polyplex nanomicelles were formulated with a therapeutic plasmid bearing the human adrenomedullin (AM) gene and intratracheally administered to rats with monocrotaline-induced pulmonary hypertension. The right ventricular pressure significantly decreased 3 days after administration as confirmed by a notable increase of pulmonary human AM mRNA levels. Intratracheal administration of PEG-b-P[Asp-(DET)] polyplex nanomicelles showed remarkable therapeutic efficacy with PAH animal models without compromising biocompatibility. 相似文献
150.
Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate 总被引:5,自引:0,他引:5
Silvia Surini Hidero Akiyama Mariko Morishita Tsuneji Nagai Kozo Takayama 《Journal of controlled release》2003,90(3):291-301
An implant controlled-release system for protein drug delivery based on a polyion complex device composed of chitosan (CS) and sodium hyaluronate (HA) was investigated. The conditions which generated the greatest amount of the polyion solid complex were studied to ascertain the formation of polyion complex between CS and HA. The greatest amount of the polyion complex was formed at the weight ratio of 3 to 7 (CS:HA) at pH 3.5. Furthermore, the CS–HA pellets were prepared and then drug release from CS–HA pellets was evaluated using insulin as a model drug. The results demonstrated that the insulin release from CS–HA pellets was markedly influenced by both the change in the polymer mixing ratio and the total pellet weight, whereas the compression pressure did not affect the release significantly. An artificial neural network (ANN) and biharmonic spline interpolation (HSI) were employed to predict the actual relation between causal factors and the release rate constant of insulin. Although both the ANN and HSI successfully represented a non-linear relationship between the formulation factors and the release rate constant, HSI methodology gave a better estimation than that of the ANN. 相似文献